Top Section/Ad
Top Section/Ad
Most recent
In Europe loans are the key to opening ancillary business while in the Middle East relationships should cap premiums
Market stress so far confined to consumer credit and SMEs across region
Tighter margin loan a 'sign of things to come' for infrastructure lending
Helaba promoted from MLA to bookrunner while RBC sits out
More articles/Ad
More articles/Ad
More articles
-
Paolo Cicchine will join Deutsche Bank as vice-chairman of global healthcare coverage. -
Allergan shareholders have waved through its acquisition by rival drug company AbbVie, clearing a major hurdle on the way to billions of dollars of loans and an expected $30bn of bond issuance.
-
Mann+Hummel, a veteran borrower in the Schuldschein market, struggled to place a Schuldschein, according to market sources, with participants citing ZF Friedrichshafen’s blockbuster transaction as well as the market’s over-indulgence in the auto sector this year as chief reasons.
-
Acquisition hungry Bravida has signed a Sk2.5bn (€197m) loan, in a deal that makes up a major part of the Nordic building facilities service provider’s long term capital structure.
-
Institutional investors from the US have been lending to German borrowers using the Namensschuldverschreibungen (NSV) — a non-callable registered instrument that is, unlike the Schuldschein, non-cancellable after 10 years. But some are sceptical of their involvement in the market, as they are of US lenders participating in the Schuldschein market.
-
The UK’s Endava has signed a new £200m-equivlanet multicurrency facility, with the software development company swapping a bilateral loan for syndicated lending.
